Publicaciones en las que colabora con Juan Antonio García Velasco (36)

2022

  1. COVID-19 mRNA vaccines have no effect on endometrial receptivity after euploid embryo transfer

    Reproductive BioMedicine Online, Vol. 45, Núm. 4, pp. 688-695

2021

  1. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis

    Reproductive BioMedicine Online, Vol. 42, Núm. 4, pp. 725-732

  2. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons

    Fertility and sterility, Vol. 115, Núm. 5, pp. 1091-1101

2020

  1. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study

    Fertility and Sterility, Vol. 113, Núm. 4, pp. 836-844

2018

  1. Elective and Onco-fertility preservation: Factors related to IVF outcomes

    Human Reproduction, Vol. 33, Núm. 12, pp. 1-10

  2. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study

    Fertility and Sterility, Vol. 109, Núm. 3, pp. 478-485.e2

2016

  1. Oocyte vitrification as an efficient option for elective fertility preservation

    Fertility and Sterility, Vol. 105, Núm. 3, pp. 755-764.e8

2015

  1. The use of morphokinetics as a predictor of implantation: A multicentric study to define and validate an algorithmfor embryo selection

    Human Reproduction, Vol. 30, Núm. 2, pp. 276-283

2013

  1. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?

    Fertility and Sterility, Vol. 99, Núm. 6, pp. 1485-1495

  2. Obesity reduces uterine receptivity: Clinical experience from 9,587 first cycles of ovum donation with normal weight donors

    Fertility and Sterility, Vol. 100, Núm. 4

2008

  1. Clinical factors affecting endometrial receptiveness in oocyte donation cycles

    Fertility and Sterility, Vol. 89, Núm. 3, pp. 491-501

2006

  1. Erratum: Evaluation of the effectiveness and clinical security of Menopur® in the ovarian stimulation in IVF-ICSI (Revista Iberoamericana de Fertilidad y Reproduccion Humana)

    Revista Iberoamericana de Fertilidad y Reproduccion Humana

  2. Evaluación de la efectividad y seguridad clínica de Menopur® en la estimulación de la ovulación en ciclos de FIV-ICSI

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 23, Núm. 4, pp. 245-255

  3. Sperm cryopreservation in oncological patients: A 14-year follow-up study

    Fertility and Sterility, Vol. 85, Núm. 3, pp. 640-645

2004

  1. Coasting acts through downregulation of VEGF gene expression and protein secretion

    Human Reproduction, Vol. 19, Núm. 7, pp. 1530-1538

2003

  1. Clinical experience and perinatal outcome of blastocyst transfer after coculture of human embryos with human endometrial epithelial cells: A 5-year follow-up study

    Fertility and Sterility, Vol. 80, Núm. 5, pp. 1162-1168

  2. Factors that determine discordant outcome from shared oocytes

    Fertility and Sterility, Vol. 80, Núm. 1, pp. 54-60

  3. Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination: A randomized study

    Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 48, Núm. 2, pp. 112-118

2002

  1. El uso de FSH recombinante a dosis de 100 UI por día alcanza resultados similares a 150 UI en inseminacíon intrauterina (IIU)

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 19, Núm. 4, pp. 253-259

  2. Oocyte and embryo quality after coasting: The experience from oocyte donation

    Human Reproduction, Vol. 17, Núm. 7, pp. 1777-1782